Brief: Windtree Announces U.S. Patent And Trademark Office Issuance Of New U.S. Istaroxime Patent
Dec 15 (Reuters) - Windtree Therapeutics Inc WINT.O :
* WINDTREE ANNOUNCES U.S. PATENT AND TRADEMARK OFFICE
ISSUANCE OF
NEW U.S. ISTAROXIME PATENT
Source text for Eikon: ID:nGNX9FhxQV
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study